Relay Therapeutics (RLAY) FCF Margin (2021 - 2026)
Relay Therapeutics' (RLAY) quarterly FCF Margin came in at 1703.73% in Q1 2026, down 74535.0% year-on-year from N/an in Q1 2025, and down 165.82% on a QoQ basis from 640.94% in Q4 2025.
Relay Therapeutics (RLAY) FCF Margin (2021 - 2026) Analysis & Trends
Relay Therapeutics (RLAY) has 6 years of FCF Margin data on file, last reported at 1703.73% in Q1 2026.
- On a quarterly basis, FCF Margin fell 74535.0% year-over-year to 1703.73% in Q1 2026; TTM through Mar 2026 was 1998.53%, a 155162.0% increase from a year earlier, with the FY2025 full-year figure at 1536.08%, up 97341.0% from the prior year.
- FCF Margin for Q1 2026 stood at 1703.73%, down from 640.94% in the prior quarter.
- Over the last five years, FCF Margin for RLAY reached as high as 8930600.0% in Q4 2023 and fell as low as 58910.92% in Q2 2023.
- Historically, FCF Margin has averaged 673613.82% across 5 years, with a median of 8166.47% in 2025.
- On a YoY basis, FCF Margin climbed as much as 895407628 bps in 2023 and fell as far as 4276024 bps in 2023.
- Year by year, FCF Margin stood at 23476.28% in 2022, then surged by 38141 bps to 8930600.0% in 2023, then sank by 100 bps to 520.67% in 2024, then fell by 23 bps to 640.94% in 2025, then sank by 166 bps to 1703.73% in 2026.
- Per Business Quant data, the three most recent FCF Margin figures were 1703.73% in Q1 2026, 640.94% in Q4 2025, and 8166.47% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 10.45% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Relay Therapeutics | 3.31 Bn | 3.31 Bn | - | -1,703.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,703.73% |
| Dec 31, 2025 | -640.94% |
| Jun 30, 2025 | -8,166.47% |
| Mar 31, 2025 | -958.38% |
| Mar 31, 2024 | -520.67% |
| Dec 31, 2023 | 8,930,600.00% |
| Sep 30, 2023 | -301.51% |
| Jun 30, 2023 | -58,910.92% |
| Mar 31, 2023 | -30,550.88% |
| Dec 31, 2022 | -23,476.28% |
| Sep 30, 2022 | -19,837.21% |
| Jun 30, 2022 | -16,150.68% |
| Mar 31, 2022 | -12,402.63% |
| Dec 31, 2021 | -7,609.35% |
| Sep 30, 2021 | -7,831.08% |
| Jun 30, 2021 | -3,405.33% |
| Mar 31, 2021 | 4,849.16% |